Carlos Frederico S Marques1, Caio Sergio R Nahas2, Ulysses Ribeiro2, Leonardo A Bustamante2, Rodrigo Ambar Pinto2, Eduardo Kenzo Mory2, Ivan Cecconello2, Sergio Carlos Nahas2. 1. Digestive Surgery, Gastroenterology Department, Hospital das Clinicas/Cancer Institute University of São Paulo Medical School, Rua Dona Adma Jafet, 74, cj172-174, Bela Vista, São Paulo, SP, 01308-050, Brazil. sparapanmarques@gmail.com. 2. Digestive Surgery, Gastroenterology Department, Hospital das Clinicas/Cancer Institute University of São Paulo Medical School, Rua Dona Adma Jafet, 74, cj172-174, Bela Vista, São Paulo, SP, 01308-050, Brazil.
Abstract
PURPOSE: Transanal endoscopic microsurgery (TEM) is a safe and efficient minimally invasive treatment for rectal benign and early malignant neoplasia, but postoperative complications may be severe. We aimed to evaluate the risk factors related to the incidence, severity, and time course of postoperative complications of TEM. METHODS: This is a prospective study of postoperative complications in 53 patients (>18 years old) with benign or early rectal neoplasia who underwent TEM with curative intention or, for higher stages, palliation. Outcome measures included age, sex, American Society of Anesthesiologists score, neoadjuvant chemoradiotherapy, lesion height and size, pathologic margins, tumor histology, and suture type. RESULTS: Overall morbidity was 50 %. Temporary fecal incontinence was the most frequent complication (17.3 %). Complication rates of Clavien-Dindo grades I and II were 21.1 % and those of grades III and IV 3.8 %. Of patients with complications, more had lesions under the first rectal valve than over the first valve (61.54 % vs 38.46 %, p = 0.04). Patients submitted to chemoradiotherapy had a 24-fold greater chance of presenting grade II complications (p = 0.002). When the surgical defect was treated using the TEM device to perform the suture, the chance of having grade III complications was reduced 16-fold (p = 0.04). Fifty-three percent of complications occurred in the first 10 days and 95 % within 20 days. CONCLUSIONS: Postoperative complications after transanal endoscopic microsurgery for the treatment of rectal neoplasia are frequent, acceptable, and usually controllable with pharmacologic treatment. Over time the nature of complications is continuous, centered on the first 20 days after surgery.
PURPOSE: Transanal endoscopic microsurgery (TEM) is a safe and efficient minimally invasive treatment for rectal benign and early malignant neoplasia, but postoperative complications may be severe. We aimed to evaluate the risk factors related to the incidence, severity, and time course of postoperative complications of TEM. METHODS: This is a prospective study of postoperative complications in 53 patients (>18 years old) with benign or early rectal neoplasia who underwent TEM with curative intention or, for higher stages, palliation. Outcome measures included age, sex, American Society of Anesthesiologists score, neoadjuvant chemoradiotherapy, lesion height and size, pathologic margins, tumor histology, and suture type. RESULTS: Overall morbidity was 50 %. Temporary fecal incontinence was the most frequent complication (17.3 %). Complication rates of Clavien-Dindo grades I and II were 21.1 % and those of grades III and IV 3.8 %. Of patients with complications, more had lesions under the first rectal valve than over the first valve (61.54 % vs 38.46 %, p = 0.04). Patients submitted to chemoradiotherapy had a 24-fold greater chance of presenting grade II complications (p = 0.002). When the surgical defect was treated using the TEM device to perform the suture, the chance of having grade III complications was reduced 16-fold (p = 0.04). Fifty-three percent of complications occurred in the first 10 days and 95 % within 20 days. CONCLUSIONS: Postoperative complications after transanal endoscopic microsurgery for the treatment of rectal neoplasia are frequent, acceptable, and usually controllable with pharmacologic treatment. Over time the nature of complications is continuous, centered on the first 20 days after surgery.
Authors: E J R de Graaf; J W A Burger; A L A van Ijsseldijk; G W M Tetteroo; I Dawson; W C J Hop Journal: Colorectal Dis Date: 2010-03-23 Impact factor: 3.788
Authors: G Lezoche; M Baldarelli; Mario Guerrieri; A M Paganini; A De Sanctis; S Bartolacci; E Lezoche Journal: Surg Endosc Date: 2007-10-18 Impact factor: 4.584
Authors: Anjali S Kumar; Jasna Coralic; Deirdre C Kelleher; Shafik Sidani; Kirthi Kolli; Lee E Smith Journal: Dis Colon Rectum Date: 2013-03 Impact factor: 4.585
Authors: Renée M Barendse; Marcel G Dijkgraaf; Ursula R Rolf; Arnold B Bijnen; Esther C J Consten; Christiaan Hoff; Evelien Dekker; Paul Fockens; Willem A Bemelman; Eelco J R de Graaf Journal: Surg Endosc Date: 2013-04-10 Impact factor: 4.584
Authors: P G Doornebosch; M P Gosselink; P A Neijenhuis; W R Schouten; R A E M Tollenaar; E J R de Graaf Journal: Int J Colorectal Dis Date: 2008-04-01 Impact factor: 2.571